3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Polycystic Ovary Syndrome
14
Breast Neoplasms
11
Prostatic Neoplasms
9
Obesity
7
Insulin Resistance
6
Carcinoma, Non-Small-Cell Lung
5
Lung Neoplasms
4
Colorectal Neoplasms
4
Motor Activity
3
Adenocarcinoma of Lung
3
Squamous Cell Carcinoma of Head and Neck
2
Pancreatic Neoplasms
2
Neoplasms
2
Menstruation Disturbances
2
Lymphoma, Large B-Cell, Diffuse
2
Head and Neck Neoplasms
2
Endometrial Neoplasms
2
Diabetes Mellitus
2
Weight Loss
1
Urothelial Cancer
1
Thyroid Diseases
1
Thoracic Neoplasms
1
Smoldering Multiple Myeloma
1
Rectal Neoplasms
1
Prediabetic State
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pleural Effusion, Malignant
1
Overweight
1
Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
1
Non-alcoholic Fatty Liver Disease
1
Interventions
fludarabine phosphate
19
Peripheral Blood Stem Cell Transplantation
15
Cyclophosphamide
15
Whole-Body Irradiation
14
Tacrolimus
13
Mycophenolic Acid
13
Busulfan
12
Antilymphocyte Serum
11
Rituximab
9
Etoposide
7
Methotrexate
6
Cyclosporine
6
Melphalan
5
thymoglobulin
4
Flow Cytometry
4
Carboplatin
4
Therapeutics
3
Radiotherapy
3
Lenalidomide
3
In Situ Hybridization, Fluorescence
3
Immunohistochemistry
3
Gene Expression Profiling
3
Filgrastim
3
Everolimus
3
Amplified Fragment Length Polymorphism Analysis
3
Alemtuzumab
3
fludarabine
2
Vorinostat
2
Vincristine
2
Transplantation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Lymphoma, Extranodal NK-T-Cell
×
Metformin
×
Clear all
No trials found.